Processing Magazine

Mylan Agrees to Settle Medicaid Case for $65 Million

January 3, 2011

According to Bloomberg, Mylan has agreed to pay $65 million to settle a lawsuit by the U.S. and Texas alleging it inflated prescription drug prices, increasing the cost of reimbursing pharmacies and other providers. The generic-drug maker, based in Pittsburgh, admitted no wrongdoing in agreeing to the payment, it said today in a statement. Since 2003, Mylan has been sued by 18 states making similar allegations, according to the company’s 2009 annual report filed with the U.S. Securities and Exchange Commission. Last year, Mylan, AstraZeneca Plc and Johnson & Johnson agreed to pay $124 million to settle claims they violated the U.S. False Claims Act by underpaying Medicaid rebates, the Justice Department said.